Check out some of the biggest movers in the premarket:
Verizon (VZ) – Verizon reported quarterly earnings of $ 1.31 a share, 2 cents a share above estimates. Sales were also better than analyst forecasts. Verizon lost more wireless subscribers during the quarter than analysts expected.
Welbilt (WBT) – Welbilt shares rose 14.8% in the premarket after professional foodservice equipment maker agreed to be bought by rival Middleby (MIDD) in an all-stock deal with an implied value of $ 4.3 billion.
Anthem (ANTM) – The health insurance company made $ 7.01 a share for the last quarter, beating estimates by 50 cents a share. Sales fell short of Wall Street’s forecasts. Anthem also raised its full-year outlook, amid the growth of its various medical plans and higher revenues from pharmacy management. The stock rose 1.6% in premarket trading.
Halliburton (HAL) – Halliburton shares rose 2.4% in premarket action after exceeding estimates by 2 cents a share, with a quarterly gain of 19 cents a share. Sales were also above estimates, with the oilfield services company saying its North American operations continue to show a healthy recovery.
Baker Hughes (BKR) – Shares of the oilfield services company surged 1.2% in premarket action after it reported quarterly earnings of 12 cents a share, a cent a share above estimates. Sales were essentially in line with expectations. Profits plummeted by 40% from a year ago, due to severe winter weather.
Nasdaq (NDAQ) – The exchange manager earned $ 1.96 a share for the first quarter, 23 cents a share above estimates. Revenues were also higher than Street forecasts. Results were boosted by double-digit increases in equity and fixed income trading income. Nasdaq also announced a 10% dividend increase.
Netflix (NFLX) – Netflix plummeted 8.7% in premarket trading, even after beating both the top and bottom lines for the last quarter. Investors are targeting weaker than expected subscriber growth for the video streaming giant.
CSX (CSX) – CSX fell 2 cents a share below estimates, with a quarterly profit of 93 cents a share. The railway operator’s revenues were above expectations. Pandemic disruptions and higher fuel costs contributed to CSX’s earnings. CSX was down 1% in premarket trading.
Moderna (MRNA) – Shares of the drug maker gained 1.1% in the premarket trade after it entered into a new Covid-19 vaccine supply agreement with Israel for 2022. Israel was also given an option to purchase vaccine doses that are designed to treat specific variants of the virus.
Norwegian Cruise Line (NCLH) – Norwegian stocks rose 2.4% in the premarket after Goldman Sachs upgraded the cruise line operator to “buy” from “neutral”. Goldman cited several positive factors, including Norway’s capacity growth and low leverage compared to its competitors.
Intuitive Surgical (ISRG) – Intuitive Surgical made $ 3.52 per share for the last quarter, well above $ 2.63 per share by consensus estimate. The surgical device manufacturer’s revenues also exceeded expectations, with procedures using the company’s devices increasing as the Covid-19 pandemic abates. The stock gained 3.9% in premarket trading.
ASML (ASML) – ASML gained 3.6% in premarket action after reporting better-than-expected profit in the first quarter as the semiconductor manufacturing equipment supplier benefits from the global rise in chip demand. ASML also raised its full-year outlook.
Tenet Healthcare (THC) – Tenet reported quarterly earnings of $ 1.30 per share, compared to 72 cents per share according to a consensus estimate. The hospital operator’s revenues were slightly higher than expected. Tenet said it was able to successfully deal with challenges related to both the pandemic and winter storms, and it also presented an optimistic outlook. Tenet added 2.7% in premarket trading.
Interactive Brokers (IBKR) – Interactive Brokers exceeded estimates at 7 cents per share, with quarterly profit of 98 cents per share. Sales were well above estimates at a 53% increase in trading commissions. The stock added 2.1% in premarket trading.
Edwards Lifesciences (EW) – Edwards shares gained 3.8% in the premarket after exceeding estimates by 7 cents a share, with a quarterly gain of 54 cents a share. Sales were also above consensus expectations, and the medical devices company also raised its full-year forecast based on an expected increase in demand for heart-related procedures.